Log in to search using one of your social media accounts:

 

Erratum: Use of a Novel Submucosal Tunneling and Endoscopic Resection (STER) Technique for the Removal of an Esophageal Leiomyoma

Erratum: Use of a Novel Submucosal Tunneling and Endoscopic Resection (STER) Technique for the Removal of an Esophageal Leiomyoma American Journal of Gastroenterology 113, 154 (January 2018). doi:10.1038/ajg.2017.427 Authors: Madhusudhan R Sanaka, Malav P Parikh, Prashanthi N Thota, Niyati M Gupta &Siva Raja
Source: The American Journal of Gastroenterology - Category: Gastroenterology Authors: Source Type: research

Related Links:

Condition:   Leiomyoma Interventions:   Drug: Vilaprisan (BAY1002670);   Drug: Placebo Sponsor:   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Leiomyoma Interventions:   Drug: Vilaprisan (BAY1002670);   Drug: Placebo Sponsor:   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Fibroid Uterus;   Fibroid Tumor;   Leiomyoma;   Fibromyoma;   Leiomyoma, Uterine Interventions:   Drug: Simvastatin 40mg;   Drug: Placebo 40 mg Sponsors:   Johns Hopkins University;   National Institutes of Health (NIH) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Leiomyoma Interventions:   Drug: Vilaprisan (BAY1002670);   Drug: Placebo Sponsor:   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Leiomyoma Interventions:   Drug: Vilaprisan (BAY1002670);   Drug: Placebo Sponsor:   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Fibroid Uterus;   Fibroid Tumor;   Leiomyoma;   Fibromyoma;   Leiomyoma, Uterine Interventions:   Drug: Simvastatin 40mg;   Drug: Placebo 40 mg Sponsors:   Johns Hopkins University;   National Institutes of Health (NIH) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
In conclusion, we confirmed the high frequency of the MED12 mutation in uterine leiomyomas of South Korean patients. We also identified various MED12 mutation status in patients with multiple leiomyomas. This suggests that in a given patient, different tumors may have arisen from different cell origins and therefore it is supposed that occurrence of multiple leiomyoma in a single patient may not be caused by intrauterine metastasis or dissemination. PMID: 29333096 [PubMed - in process]
Source: International Journal of Medical Sciences - Category: Biomedical Science Tags: Int J Med Sci Source Type: research
ConclusionsThe etiological diagnosis of acute intestinal obstruction during pregnancy is not easy, especially in the context of a low-income country where the means of biological and radiological diagnosis are lacking. A laparotomy is required before diagnosis of acute surgical abdomen and its management will depend on the intraoperative findings and the condition of the patient.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
In this study, we report the case of a 27-year-old misdiagnosed carrier of HLRCC phenotype, who presented with a large solitary Type II papillary RCC.
Source: Urology Annals - Category: Urology & Nephrology Authors: Source Type: research
This article is protected by copyright. All rights reserved.
Source: Digestive Endoscopy - Category: Gastroenterology Authors: Tags: DEN Video Article Source Type: research
More News: Gastroenterology | Leiomyoma